<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02236429</url>
  </required_header>
  <id_info>
    <org_study_id>VFT-HMO-CTIL</org_study_id>
    <nct_id>NCT02236429</nct_id>
  </id_info>
  <brief_title>Vaginal Flora for Treatment of Bacterial Vaginosis</brief_title>
  <acronym>VFT</acronym>
  <official_title>Vaginal Flora Transplantation for Recurrent Bacterial Vaginosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bacterial vaginosis (BV) is the most common vaginal infection in women. It is caused by a
      vaginal bacterial imbalance. Treatment with antibiotics is the standard of care but there is
      a high rate of recurrence. Almost half of women successfully treated suffer a recurrence
      within three months. Complications include risk factors for premature birth, increased
      transmission of sexually transmitted diseases and higher risk for carcinoma of cervix. The
      investigators proposed study is a cost effective treatment based on returning the normal
      microbial balance to the vagina. The investigators propose to transfer normal vaginal flora
      from healthy individuals to women with BV and thus restore normal vaginal flora and cure this
      disorder.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>relief of bacterial vaginosis</measure>
    <time_frame>12 month</time_frame>
    <description>Clinical cure, i.e., absence of vaginal discharge and malodor</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Laboratory parameters</measure>
    <time_frame>12 months</time_frame>
    <description>absence of all Amsel criteria and Nugent score&lt;3.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Recurrent Bacterial Vaginitis</condition>
  <arm_group>
    <arm_group_label>recurrent bacterial vaginitis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>vaginal flora transplant</intervention_name>
    <arm_group_label>recurrent bacterial vaginitis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  recurrent BV (4 or more incidences in the past year)

          -  recurrence of BV in less than 2 months of antibiotic treatment or need for
             prophylactic antibiotic

          -  3/4 Amsel criteria and Nugent criteria greater or equal to 7

        Exclusion Criteria:

          -  pregnancy or planned pregnancy during the study period

          -  other known diseases

          -  carriers of Hep B and C

          -  HIV or syphilis positive
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahinoam Lev-Sagie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Mediocal Organization</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ahinoam Lev-Sagie, MD</last_name>
    <phone>+972-544327178</phone>
    <email>levsagie@netvision.net.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hadas Lemberg, PhD</last_name>
      <phone>00 972 2 6777572</phone>
      <email>lhadas@hadassah.org.il</email>
    </contact>
    <investigator>
      <last_name>Ahinoam Lev-Sagie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2014</study_first_submitted>
  <study_first_submitted_qc>September 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2014</study_first_posted>
  <last_update_submitted>February 28, 2017</last_update_submitted>
  <last_update_submitted_qc>February 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>bacterial vaginitis</keyword>
  <keyword>vaginal flora</keyword>
  <keyword>microbiome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaginosis, Bacterial</mesh_term>
    <mesh_term>Vaginitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

